A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...
When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...
A new publication from Opto-Electronic Advances; DOI 10.29026/oea.2024.240105, discusses a high-resolution tumor marker detection based on microwave photonics demodulated dual wavelength fiber laser ...
Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Cancer Although ...
Over a 1-year period, the mean number of any individual test per patient was seven tests, and the maximum number was 35 tests; the mean number of total tests per patient was 12 tests, and the maximum ...
Using a single blood sample, multi-cancer early detection (MCED) tests screen for numerous types of cancers, including breast, ovarian, colorectal, pancreatic and prostate cancers. Trials are underway ...
Blood tests that promise to spot cancer before symptoms appear are racing toward clinics, pitched as a simple vial of blood that could replace invasive biopsies and catch tumors when they are still ...
Researchers at NYU Langone Health and its Perlmutter Cancer Center have revealed that blood tests could predict the return of skin cancer. Melanoma is a less common form of skin cancer that is more ...
A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback